On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Västra Götaland region, Sweden

Peter Johansson(Linköping University), Jack Kutti(Sahlgrenska University Hospital), C. RHEDIN(University of Borås), Lars Vilén(Sahlgrenska University Hospital), Björn Andréasson(NU Hospital Group), Soodabeh Safai‐Kutti(Sahlgrenska University Hospital), Jan G.M. Van Der Vaart(Skaraborg Hospital)

Journal of Internal Medicine

April 1, 2002

10.1046/j.1365-2796.2002.00968.x

Cited by 9

Related Papers

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

|Journal of Clinical Oncology|2012|461

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

|Blood|2011|340

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

|Journal of Clinical Oncology|2011|244

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

|The Lancet|2023|194

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

|Blood|2014|153